Evercare hospital successfully treats Bangladesh’s first cases of MIS-C linked to Covid-19
The patients at Evercare were a 3-and-a-half-month-old girl and a boy who was 2 years and 2 months old
Evercare hospital in Dhaka has successfully treated Bangladesh's first cases of Multisystem Inflammatory Syndrome in Children (MIS-C) disease linked to Covid-19.
Senior consultant of Pediatrics Dr. M Quamrul Hassan and Dr Tahera Nazrin, consultant Pediatric Cardiologist along with the pediatric and intensive care team at Evercare diagnosed two such cases on May 15, 2020 and successfully treated the patients said a press release issued by the hospital on Thursday.
Multisystem Inflammatory Syndrome in Children (MIS-C) or Pediatric Multi system Inflammatory Syndrome (PMIS) is a disease that can cause widespread inflammation restricting blood flow and damaging multiple organs like the heart, kidney, and liver. Its features are similar to that of Kawasaki disease and Toxic Shock Syndrome.
The Centre for Disease Control (CDC) in the United States has suggested there is a correlation between Covid-19 and MIS-C. Evidence from positive antibody tests indicate numerous children with MIS-C had been affected by Covid-19 in the past, some even without showing any symptoms of it said the press release.
The patients at Evercare were a 3-and-a-half-month-old girl and a boy who was 2 years and 2 months old.
Both children presented with high fever of 102 to 105 °F for 5 and 7 days respectively and had diarrhea, congested eyes, red lips, and mild swelling of feet the released added.
There was significant involvement of the heart with widening of their coronary arteries which supply blood to the heart itself. The older child also experienced convulsion and went on to suffer from swelling of heart chambers, low blood pressure and heart failure.
The boy had also tested positive for Covid-19 in a Reverse Transcription Polymerase Chain Reaction (RT-PCR) test.
Although the little girl tested negative, her family members all tested positive soon after.
The male child required treatment in the Intensive Care Unit (ICU). Both patients had to be closely monitored and were given Intravenous Immunoglobulin (IVIG) – a mixture of antibodies, prepared from the blood plasma of healthy donors, which can help fight infection and inflammation.
They were discharged from the hospital as their conditions stabilized and improved significantly following treatment, said the press release.
